While telemedicine is proving a lifeline for many hospitals during the current crisis, it doesn’t allow for routine heartworm testing and the administration of certain medications.
To address these issues, the American Heartworm Society (AHS) issued new recommendations to help hospitals and shelters better manage heartworm treatment at a time when many have cancelled routine wellness visits, or, worse, closed their doors for the short term.
NEWStat reached out to American Heartworm Society President Chris Duke, DVM, to find out more about the recommendations.